Feature | February 10, 2014

Inflammation Testing May Predict Cardiac Risk in Corporate Wellness Programs

February 10, 2014 — Traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term cardiovascular risk in employed populations, according to Jake Orville, CEO of Cleveland HeartLab (CHL). This position is supported by data from the American Heart Association. AHA reported 50 percent of all heart attacks and strokes occur in individuals with normal cholesterol and — for approximately 30 percent of patients with cardiovascular disease — their first sign of disease is death.
 
Orville is scheduled to present "The Role of Inflammation Testing in Corporate Wellness Programs" at the 2014 Health & Wellness Congress, Feb. 27-28. The conference, held at the Monte Carlo Resort and Casino in Las Vegas, will bring together leading corporate wellness experts to discuss emerging trends and strategies that promote well-being at the worksite.
 
"Inflammation testing provides reassurance on another important level," Orville said. "In addition to detecting employees with possible hidden risk, we are also able to provide positive feedback for those employees who are already leading healthy lifestyles. Knowing that their health habits are decreasing the inflammation in their blood vessels and their risk of an event can be a powerful incentive for people to stick with positive lifestyle changes."
 
Cleveland HeartLab is a provider of onsite testing for corporate wellness programs. A clinical laboratory and cardiovascular disease management provider, CHL offers a multi-marker approach — adding inflammation-specific blood tests to the traditional screening panel — to identify employees may go undetected. CHL's inflammatory biomarkers deliver insight into cardiovascular disease risk such as "vulnerable plaque" that may rupture into the vessel and block blood flow, leading to heart attack or stroke.
 
Orville will present both the science of inflammation testing and the results of corporate wellness programs that have adopted inflammation testing for risk stratification and targeted intervention. With new mandates from the Affordable Care Act for companies to provide screening programs to employees, obtaining the greatest efficacy as well as return on investment becomes paramount.
 
For more information: www.clevelandheartlab.com

Related Content

Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients
News | Heart Failure| May 26, 2017
Recent outcomes from the MAVERIC clinical trial confirm earlier positive findings that MVRx’s Arto System safely and...
Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve
News | Heart Valve Technology| May 24, 2017
May 24, 2017 — Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for...
Shockwave Medical Announces CE Mark for Coronary Lithoplasty System and Activities at EuroPCR 2017
News | Cath Lab| May 23, 2017
Shockwave Medical announced last week CE Mark for the company’s Coronary Lithoplasty System for the treatment of...
Consumers Warned About Accuracy of Heart Rate Apps in New Study
News | Mobile Devices| May 22, 2017
May 22, 2017 — Consumers are being warned about the accuracy of heart rate apps after a study found huge variability
Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Arterial Disease (PAD)| May 17, 2017
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon...
Early Treatment for NSTEMI Patients Shows Greater Rate of Survival
News | Cath Lab| May 16, 2017
An analysis of non ST-elevation myocardial infarction (NSTEMI) patients who undergo coronary revascularization within...
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Overlay Init